Generic Name and Formulations:
Betrixaban 40mg, 80mg; caps.
Indications for BEVYXXA:
Prophylaxis of venous thromboembolism (VTE) in adults hospitalized for an acute medical illness who are at risk for thromboembolic complications.
Limitations Of use:
Safety and efficacy not established in patients with prosthetic heart valves.
Take with food. Initially 160mg as a single dose, followed by 80mg once daily for 35–42 days. Severe renal impairment (CrCl ≥15–<30mL/min) or concomitant P-gp inhibitors: initially 80mg as a single dose, followed by 40mg once daily for 35–42 days.
Active pathological bleeding.
Increased risk of spinal/epidural hematoma in anticoagulated patients receiving neuraxial anesthesia or undergoing spinal puncture (see full labeling); monitor for signs/symptoms of neurological impairment. Increased risk of bleeding; monitor for signs/symptoms of blood loss; discontinue if active pathological hemorrhage occurs. Severe renal impairment: reduce Bevyxxa dose (see Adult); monitor closely and evaluate any signs/symptoms of blood loss. Hepatic impairment: not recommended. Labor & delivery. Pregnancy: risk of pregnancy-related hemorrhage. Nursing mothers.
Increased risk of bleeding with concomitant aspirin, antiplatelets, anticoagulants, heparin, thrombolytics, SSRIs, SNRIs, and NSAIDs. Potentiated by P-gp inhibitors (eg, amiodarone, azithromycin, verapamil, ketoconazole, clarithromycin): reduce Bevyxxa dose (see Adult); monitor closely and evaluate any signs/symptoms of blood loss. Severe renal impairment (CrCl ≥15–<30mL/min): do not use Bevyxxa if receiving concomitant P-gp inhibitor.
Factor Xa inhibitor.
Bleeding events (may be serious or fatal), urinary tract infection, constipation, hypokalemia, hypertension, headache, nausea, diarrhea, hypersensitivity reactions.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- #MeToo: Helping Victims Cope With Sexual Harassment
- Association Between Psychosis and Development of Dementia in Older Men
- Phonemic Verbal Advantage in Mild Cognitive Impairment May Predict Risk for Alzheimer Disease
- Psychosis Could Be a Potential Side Effect of Steroid Treatment in Kids
- Guidance Offered for Improving Mental Health in Workplace
- Triiodothyronine in the Treatment of Bipolar Depression
- Nutritional Influences on Bipolar Disorder in Children
- Old Challenges and New Directions in Managing Tardive Dyskinesia
- Early Intervention Strategies for Bipolar Disorder: Clinical Dilemmas and Directions
- Similar Rates of Childhood Trauma in Schizophrenia and Substance Use Disorders
- Bully for Us: Confronting Medicine's Bullying Problem
- Personality Functioning Associated With Global Functioning in Bipolar Disorder I
- Higher Incidence of Mania in Adults With Intellectual Disabilities vs General Population
- Youth With Gender Nonconformity Vulnerable to Adversity
- Negative Affect That Lingers Tied to Health 10 Years Later